Abstract

CD8+ T cell tissue resident memory (TRM) cells are especially suited to control pathogen spread at mucosal sites. However, their maintenance in lung is short-lived. TCR-dependent NFkB signaling is crucial for T cell memory but how and when NFkB signaling modulates tissue resident and circulating T cell memory during the immune response is unknown. Here, we find that enhancing NFkB signaling in T cells once memory to influenza is established, increases pro-survival Bcl-2 and CD122 levels thus boosting lung CD8+ TRM maintenance. By contrast, enhancing NFkB signals during the contraction phase of the response leads to a defect in CD8+ TRM differentiation without impairing recirculating memory subsets. Specifically, inducible activation of NFkB via constitutive active IKK2 or TNF interferes with TGFβ signaling, resulting in defects of lung CD8+ TRM imprinting molecules CD69, CD103, Runx3 and Eomes. Conversely, inhibiting NFkB signals not only recovers but improves the transcriptional signature and generation of lung CD8+ TRM. Thus, NFkB signaling is a critical regulator of tissue resident memory, whose levels can be tuned at specific times during infection to boost lung CD8+ TRM.

CD8+ T resident memory (TRM) cells are important in protection against virus infection and NFκB signalling may function in this process. Here the authors use an inducible transgenic mouse models where T cell intrinsic NFκB levels can be increased or decreased which affects how CD8+ TRM cells seed into the lungs after influenza infection.

Details

Title
IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection
Author
Pritzl, Curtis J. 1   VIAFID ORCID Logo  ; Luera, Dezzarae 1   VIAFID ORCID Logo  ; Knudson, Karin M. 2 ; Quaney, Michael J. 2 ; Calcutt, Michael J. 3 ; Daniels, Mark A. 1   VIAFID ORCID Logo  ; Teixeiro, Emma 1   VIAFID ORCID Logo 

 University of Missouri, Department of Molecular Microbiology and Immunology, School of Medicine, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504); University of Missouri, Roy Blunt NextGen Precision Health Building, School of Medicine, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504) 
 University of Missouri, Department of Molecular Microbiology and Immunology, School of Medicine, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504) 
 University of Missouri, Department of Veterinary Pathobiology, Columbia, USA (GRID:grid.134936.a) (ISNI:0000 0001 2162 3504) 
Pages
4331
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2839651482
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.